We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The new Bimzelx administration and dosage is available ...

(RTTNews) - UCB announced that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX is now available. These are in addition to the 1 mL device administration ...

Doctors prescribe Bimzelx (bimekizumab-bkzx) for several conditions in adults. Common side effects of the drug include headaches, fatigue, and reactions at the injection site. Serious side effects of ...

BIMZELX ® (bimekizumab-bkzx) is now commercially available by prescription in the United States in a 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX The single-injection ...

Following an examination of clinical evidence and stakeholder input, Canada's Drug Agency (CDA-AMC) has recommended BIMZELX® (bimekizumab injection) for reimbursement with conditions for patients with ...

Credit: UCB The new presentations allow for single administration for certain indications. The new presentations allow for single administration to treat plaque psoriasis, hidradenitis suppurativa, ...

Clinically meaningful improvements observed with BIMZELX over one year of treatment were maintained up to two years (Week 96) At Week 96, over eight in 10 patients treated with BIMZELX achieved ...

OAKVILLE, ON, June 9, 2026 /CNW/ - UCB Canada Inc. today announced that Canada's Drug Agency (CDA-AMC) has issued a positive recommendation to reimburse BIMZELX® (bimekizumab injection) with ...